KARYOTYPIC CHANGE FROM HETEROPLOIDY TO NEAR DIPLOIDY ASSOCIATED WITH DEVELOPMENT OF CISPLATIN RESISTANCE IN A RAT OVARIAN TUMOR-CELL LINE

被引:15
作者
CHEN, G
HUTTER, KJ
BULLERDIEK, J
ZELLER, WJ
机构
[1] GERMAN CANC RES CTR,INST TOXICOL & CHEMOTHERAPY,W-6900 HEIDELBERG,GERMANY
[2] GERMAN CANC RES CTR,INST RADIOL & PATHOPHYSIOL,W-6900 HEIDELBERG,GERMANY
[3] UNIV BREMEN,CTR HUMAN GENET & GENET COUNSELLING,W-2800 BREMEN 33,GERMANY
关键词
CISPLATIN RESISTANCE; OVARIAN TUMOR CELL LINE; KARYOTYPIC CHANGE; FLOW CYTOMETRY;
D O I
10.1007/BF01613285
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a rat ovarian tumour cell line a 33-fold resistance to cisplatin (O-342/DDP) was developed in vitro by continuous exposure of the parental cell line (O-342) to stepwise increase cisplatin concentration in the culture medium. Both cell lines had a similar growth rate in vitro. Development of resistance was accompanied by a change of the karyotype from heteroploidy in chemosensitive O-342 cells to near diploidy in resistant O-342/DDP cells as shown by chromosome number distribution. This finding was confirmed by measuring cellular DNA content using flow-cytometry analysis. Flow karyotyping showed significant differences in chromosomal DNA contents between both cell lines. Our results suggest that the parent line O-342 consists of at least two subpopulations, a cisplatin-sensitive and a cisplatin-resistant one, corresponding to hyperploidy and near diploidy, respectively. Continuous cisplatin exposure of O-342 cells selectively killed the sensitive fraction, resulting in the karyotypic change observed.
引用
收藏
页码:539 / 542
页数:4
相关论文
共 18 条
[1]   INVITRO INVESTIGATIONS ON INDUCTION AND REVERSAL OF CISPLATIN RESISTANCE IN A RAT OVARIAN TUMOR-CELL LINE [J].
CHEN, G ;
ZELLER, WJ .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1990, 116 (05) :443-447
[2]   RESISTANCE TO CISPLATIN AND ANALOGS - MECHANISMS AND POTENTIAL CLINICAL IMPLICATIONS [J].
DEGRAEFF, A ;
SLEBOS, RJC ;
RODENHUIS, S .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 22 (04) :325-332
[3]   TUMOR HETEROGENEITY AND DRUG-RESISTANCE [J].
DEXTER, DL ;
LEITH, JT .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (02) :244-257
[4]  
FUTTERMAN G, 1989, 2 HEID FLOW ZYT S, P7
[5]  
GOLDIE JH, 1985, SEMIN ONCOL, V12, P222
[6]  
HEIM S, 1987, CANCER CYTOGENETICS, P23
[7]   CHROMOSOME ERROR PROPAGATION AND CANCER [J].
HOLLIDAY, R .
TRENDS IN GENETICS, 1989, 5 (02) :42-45
[8]   DETECTION AND SEPARATION OF THE SUBMETACENTRIC MARKER CHROMOSOME OF THE WALKER (W-256) CARCINOMA USING FLOW-CYTOMETRY AND SORTING [J].
HUTTER, KJ ;
STOEHR, M .
HISTOCHEMISTRY, 1985, 82 (05) :469-475
[9]   INFLUENCE OF CISPLATIN ON CELL-CYCLE PROGRESSION IN XENOGRAFTED HUMAN HEAD AND NECK CARCINOMAS [J].
JACKEL, M ;
KOPFMAIER, P .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 27 (06) :464-471
[10]   DNA CONSTANCY IN HETEROPLOIDY AND STEM LINE THEORY OF TUMORS [J].
KRAEMER, PM ;
PETERSEN, DF ;
VANDILLA, MA .
SCIENCE, 1971, 174 (4010) :714-+